These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 15248138)

  • 1. Clinical characteristics of gastrointestinal lymphomas associated with AIDS (GI-ARL) and the impact of HAART.
    Srinivasan S; Takeshita K; Holkova B; Czuczman MS; Miller K; Bernstein ZP; Driscoll D; Chanan-Khan A
    HIV Clin Trials; 2004; 5(3):140-5. PubMed ID: 15248138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Non-Hodgkin's lymphomas of the digestive tract and anexal glands in AIDS patients].
    Corti M; Villafañe Fioti MF; Lewi D; Schtirbu R; Narbaitz M; de Dios Soler M
    Acta Gastroenterol Latinoam; 2006 Dec; 36(4):190-6. PubMed ID: 17225446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved survival and chemotherapy response among patients with AIDS-related non-Hodgkin's lymphoma receiving highly active antiretroviral therapy.
    Diamond C; Taylor TH; Im T; Miradi M; Anton-Culver H
    Hematol Oncol; 2006 Sep; 24(3):139-45. PubMed ID: 16604565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serbian lymphoma study group (SLG): the prognosis of AIDS-related non-Hodgkin's lymphoma.
    Djunic I; Jevtovic DL; Ranin J; Salemovic D; Tomin D; Mihaljevic B
    Biomed Pharmacother; 2008 Jan; 62(1):12-5. PubMed ID: 17629445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changing incidence and prognostic factors of survival in AIDS-related non-Hodgkin's lymphoma in the era of highly active antiretroviral therapy (HAART).
    Wolf T; Brodt HR; Fichtlscherer S; Mantzsch K; Hoelzer D; Helm EB; Mitrou PS; Chow KU
    Leuk Lymphoma; 2005 Feb; 46(2):207-15. PubMed ID: 15621803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial effect of highly active antiretroviral therapy on the prognosis of AIDS-related systemic non-Hodgkin lymphomas.
    Lascaux AS; Hemery F; Goujard C; Lesprit P; Delfraissy JF; Sobel A; Lepage E; Lévy Y
    AIDS Res Hum Retroviruses; 2005 Mar; 21(3):214-20. PubMed ID: 15795527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features and predictors of survival of AIDS-related non-Hodgkin's lymphoma in a population-based case series in Sydney, Australia.
    Robotin MC; Law MG; Milliken S; Goldstein D; Garsia RJ; Dolan GM; Kaldor JM; Grulich AE
    HIV Med; 2004 Sep; 5(5):377-84. PubMed ID: 15369514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AIDS and non-Hodgkin's lymphoma. Experience at an oncological center in Mexico.
    Cornejo-Juárez P; Volkow-Fernández P; Avilés-Salas A; Calderón-Flores E
    Rev Invest Clin; 2008; 60(5):375-81. PubMed ID: 19227434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in acquired immunodeficiency syndrome-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: incidence, presentation, treatment, and survival.
    Diamond C; Taylor TH; Aboumrad T; Anton-Culver H
    Cancer; 2006 Jan; 106(1):128-35. PubMed ID: 16329140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response to highly active antiretroviral therapy strongly predicts outcome in patients with AIDS-related lymphoma.
    Hoffmann C; Wolf E; Fätkenheuer G; Buhk T; Stoehr A; Plettenberg A; Stellbrink HJ; Jaeger H; Siebert U; Horst HA
    AIDS; 2003 Jul; 17(10):1521-9. PubMed ID: 12824790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of highly active antiretroviral therapy on survival in patients with AIDS-associated pulmonary Kaposi's sarcoma treated with chemotherapy.
    Holkova B; Takeshita K; Cheng DM; Volm M; Wasserheit C; Demopoulos R; Chanan-Khan A
    J Clin Oncol; 2001 Sep; 19(18):3848-51. PubMed ID: 11559722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Favorable impact of virological response to highly active antiretroviral therapy on survival in patients with AIDS-related lymphoma.
    Navarro JT; Ribera JM; Oriol A; Romeu J; Sirera G; Mate JL; Batlle M; Xicoy B; Grau J; Millá F; Feliu E
    Leuk Lymphoma; 2002 Sep; 43(9):1837-42. PubMed ID: 12685841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Better response to chemotherapy and prolonged survival in AIDS-related lymphomas responding to highly active antiretroviral therapy.
    Antinori A; Cingolani A; Alba L; Ammassari A; Serraino D; Ciancio BC; Palmieri F; De Luca A; Larocca LM; Ruco L; Ippolito G; Cauda R
    AIDS; 2001 Aug; 15(12):1483-91. PubMed ID: 11504980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highly active antiretroviral therapy is associated with improved survival among patients with AIDS-related primary central nervous system non-Hodgkin's lymphoma.
    Diamond C; Taylor TH; Im T; Miradi M; Wallace M; Anton-Culver H
    Curr HIV Res; 2006 Jul; 4(3):375-8. PubMed ID: 16842088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and immunologic profile of AIDS-related lymphoma in the era of highly active antiretroviral therapy.
    Barclay LR; Buskin SE; Kahle EM; Aboulafia DM
    Clin Lymphoma Myeloma; 2007 Jan; 7(4):272-9. PubMed ID: 17324334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Report of AIDS-related lymphoma in South Korea.
    Kim JS; Kim SJ; Kim JS; Kim ES; Shin HJ; Chung JS; Min YH; Lee MH; Choi YJ; Bang SM; Kim JA; Cho GJ; Chi HS; Jang SS; Park CJ; Suh C; Park CW; Kim CS;
    Jpn J Clin Oncol; 2008 Feb; 38(2):134-9. PubMed ID: 18263652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presentation and outcomes of systemic non-Hodgkin's lymphoma: a comparison between patients with acquired immunodeficiency syndrome (AIDS) treated with highly active antiretroviral therapy and patients without AIDS.
    Diamond C; Taylor TH; Im T; Anton-Culver H
    Leuk Lymphoma; 2006 Sep; 47(9):1822-9. PubMed ID: 17064995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-associated non-Hodgkin's lymphoma of the gastrointestinal tract.
    Beck PL; Gill MJ; Sutherland LR
    Am J Gastroenterol; 1996 Nov; 91(11):2377-81. PubMed ID: 8931421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Non Hodgkin's and Hodgkin's lymphomas and HIV: frequency, outcome and immune response under HAART; Clermont-Ferrand University Hospital, 1991-2003].
    Jacomet C; Lesens O; Villemagne B; Darcha C; Tournilhac O; Henquell C; Cormerais L; Gourdon F; Peigue-Lafeuille H; Travade P; Beytout J; Laurichesse H
    Med Mal Infect; 2006 Mar; 36(3):157-62. PubMed ID: 16503104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AIDS-related Burkitt's lymphoma versus diffuse large-cell lymphoma in the pre-highly active antiretroviral therapy (HAART) and HAART eras: significant differences in survival with standard chemotherapy.
    Lim ST; Karim R; Nathwani BN; Tulpule A; Espina B; Levine AM
    J Clin Oncol; 2005 Jul; 23(19):4430-8. PubMed ID: 15883411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.